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The National Institute of Health (INSA) is the state laboratory in the health sector. INSA has a 
long tradition in investigating the molecular etiology of genetic and complex diseases and in the 
identification of pathogenic organisms responsible for disease outbreaks and environmental 
imbalances. These activities benefit greatly from the existing centralized sequencing services 
provided by the Technology and Innovation Unit (UTI). Its mission includes performing 
sequencing and genotyping assays in the framework of research, diagnosis and epidemiological 
surveillance, as well as implementing data analysis pipelines for the study of variation in human 
genes. The equipment portfolio includes two next-generation sequencers and two capillary 
electrophoresis instruments for Sanger sequencing/fragment analysis, that altogether process 
an average of 36.000 samples/year. The team performed over 300 next-generation sequencing 
workflows for small genomes, amplicons, gene panels, clinical exome, 16S rRNA gene and 
RNA/microRNAs. Standard of operation procedures are conducted by trained technicians under 
a quality control system that includes external quality assessment and ISO 15189 accreditation. 
UTI plays a key role in public health genomics, providing state-of-the-art equipment, centralized 
resources, technical expertise and short response times for public health problems (This work 
was supported by Centre for Toxicogenomics and Human Health - UID/BIM/00009/2019 - and 
GenomePT project – POCI-01-0145-FEDER-022184). 
